Premium Exclusive

Where Medicare’s $35 monthly insulin cap could mean big savings

The Inflation Reduction Act capped the monthly out-of-pocket cost of insulin at $35 for Medicare Part D subscribers on Jan. 1. Starting July 1, Medicare Part B enrollees will also have a $35 cap per monthly prescription. Among people who use insulin, about 52 percent of them are Medicare beneficiaries, according to HHS.

Fill out the form to access this premium content.

Copy link
Powered by Social Snap